Target intelligence / Profile preview

Bladder uroepithelium

Molecular classification
Other
01

Overview

The bladder uroepithelium, also known as the urothelium, is the specialized stratified epithelium that lines the urinary tract, including the renal pelvis, ureters, and bladder [StatPearls]. Its primary biological function is to serve as a highly impermeable blood-urine barrier, preventing the reabsorption of toxic waste products and protecting underlying tissues from the chemical composition of urine [NIH]. This barrier is maintained by specialized apical "umbrella cells" and a unique layer of uroplakin proteins [PubMed]. Beyond its structural role, the urothelium acts as a sensory organ that responds to mechanical stretch and chemical stimuli by releasing signaling molecules like ATP and acetylcholine to communicate with the underlying nervous system [Nature Reviews Urology]. Pathologically, the urothelium is the site of origin for the majority of bladder cancers (urothelial carcinomas) and is central to the pathophysiology of inflammatory conditions like interstitial cystitis [NCI]. While the urothelium is a tissue rather than a single molecular target, it contains numerous receptors and transporters that are targeted by drugs for overactive bladder, pain, and malignancy [Journal of Urology]. Therapeutic strategies often involve intravesical administration of agents to maximize local concentration while minimizing systemic side effects [StatPearls].

Other names
UrotheliumTransitional epitheliumBladder liningUroepithelium
02

Mechanism of action

The bladder uroepithelium is a tissue layer and does not possess a single molecular mechanism of action; drugs targeting this tissue act through diverse pathways such as immune-mediated cytotoxicity, DNA cross-linking, or modulation of autonomic signaling via muscarinic or adrenergic receptors [StatPearls, NCI].

03

Biological functions

Barrier functionMechanosensationSignal transductionUrine storage
04

Disease associations

CancerInflammationInfection
05

Safety considerations

Chemical cystitisSystemic absorption of intravesical agentsUrothelial denudationBladder wall perforationIrritative voiding symptoms
06

Interacting drugs

Bacillus Calmette-Guerin

5 more in the full profile.

07

Biomarkers

Uroplakin 1A (UPK1A)Uroplakin 2 (UPK2)Uroplakin 3A (UPK3A)Cytokeratin 7 (CK7)Cytokeratin 20 (CK20)GATA3

Beyond the preview

Go deeper on Bladder uroepithelium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bladder uroepithelium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call